
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
One of the hallmarks of the 21st century medicine is the emergence of digital therapeutics (DTx)—evidence-based, clinically validated digital technologies to prevent, diagnose, treat, and manage various diseases and medical conditions. DTx solutions have been gaining interest from patients, investors, healthcare providers, health authorities, and other stakeholders because of the potential of DTx to deliver equitable, massively scalable, personalized and transformative treatments for different unmet medical needs. Digital Therapeutics: Scientific, Statistical, Clinical, and Regulatory Aspects is an unparalleled summary of the current scientific, statistical, developmental, and regulatory aspects of DTx which is poised to become the fastest growing area of the biopharmaceutical and digital medicine product development. This edited volume intends to provide a systematic exposition to digital therapeutics through 19 peer-reviewed chapters written by subject matter experts in this emerging field. This edited volume is an invaluable resource for business leaders and researchers working in public health, healthcare, digital health, information technology, and biopharmaceutical industries. It will be also useful for regulatory scientists involved in the review of DTx products, and for faculty and students involved in an interdisciplinary research on digital health and digital medicine. Key Features: Provides the taxonomy of the concepts and a navigation tool for the field of DTx. Covers important strategic aspects of the DTx industry, thereby helping investors, developers, and regulators gain a better appreciation of the potential value of DTx. Expounds on many existing and emerging state-of-the art scientific and technological tools, as well as data privacy, ethical and regulatory considerations for DTx product development. Presents several case studies of successful development of some of the most remarkable DTx products. Provides some perspectives and forward-looking st
Digital therapeutics (DTx) represent a paradigm shift in 21st-century medicine, offering evidence-based digital solutions for disease prevention, diagnosis, treatment, and management. This edited volume systematically explores the scientific, statistical, developmental, and regulatory facets of DTx, a rapidly growing area in biopharmaceutical and digital medicine product development. It aims to provide a comprehensive overview for a diverse audience, including business leaders, researchers, and regulatory scientists, by synthesizing current knowledge and future perspectives in the field.
This volume is positioned as an unparalleled summary of the current landscape of digital therapeutics, intended to be an invaluable resource for professionals across public health, healthcare, digital health, information technology, and the biopharmaceutical industries. Its comprehensive approach, covering scientific, statistical, clinical, and regulatory aspects, aims to provide a deep appreciation of DTx potential value. The inclusion of case studies and expert perspectives suggests a practical and forward-looking resource for those involved in the development and regulation of these emerging technologies.
Page Count:
462
Publication Date:
2022-12-06
Publisher:
Taylor & Francis
ISBN-10:
1000799379
ISBN-13:
9781000799378
No comments yet. Be the first to share your thoughts!